
Astellas Pharma Europe, Middle East and Africa has appointed Eugene Van Rensburg to the position of chief financial officer, from …

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …

Draft guidance issued by NICE has seen rejections for products including Celgene’s Otelza and Astellas Pharma’s Xtandi, and a call …
Astellas Pharma and Anokion are to collaborate and develop new treatments for type 1 diabetes and celiac disease in a deal that could net …

Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …
The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

There are plenty of advances in oncology treatments to be excited about – from immunotherapy to cancer vaccines and monoclonal …
Big data has taken quite a knocking over the past year. First, from some sceptics who have warned big data …

A recent pharma survey has found that a majority of Britons lack confidence in the NHS to keep their personal …

Healthcare marketing consultancy Cello Health Consulting has appointed pharma marketer Jon Gilbert as a senior consultant. Gilbert joins the agency …

Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …
Last week Astellas announced the winner of its Science, Technology, Engineering, and Mathematics (STEM) skills Innovation Challenge competition at an …

Marketing communications group Creston has announced that its Creston Health arm will now be rebranded as Health Unlimited. Under the …
Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …